This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a ... Empagliflozin (Jardiance) to treat type 2
Little treatments, lots of time best for back pain | Internal Medicine Meeting 2019 News | ACP Internist
catastrophizing, avoiding activities out of fear (of further injury, for example), and having depression, anxiety, obesity, comorbidities such as diabetes, headaches, or asthma, or a physically demanding job, Dr.
This update also covers a risk evaluation and mitigation strategy for liraglutide and approval of a new PCSK9 inhibitor.
found. Researchers conducted a retrospective cohort study of more than 584,000 encounters for more than 27,000 patients with diabetes and elevated A1C, blood pressure and/or LDL. ... Many studies have shown that midlevel providers can be more effective
This issue covers topics including management of diabetes in the elderly, the public release of Medicare payments to physicians, and new approaches to antivirals as flu season begins. ... As part of managing diabetes therapy in their practice, internists
QD: News Every Day--Teens with type 2 diabetes likely to need combination therapy sooner. ... A majority of teenagers with type 2 diabetes may require combination treatment or insulin therapy within a few years of diagnosis, researchers concluded.
The FDA continues to investigate and has not determined whether the diabetes drug increases the risk of leg and foot amputations.
Changes in alcohol consumption and subsequent risk of type 2 diabetes in men. ... Diabetes. 2011;60:74-9. [PMID: 20876712]. Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, et al.
Insulin degludec injection (Tresiba) and insulin degludec/insulin aspart injection (Ryzodeg 70/30) to improve glucose control in adults with diabetes. ... The former agent, a long-acting insulin analog for both type 1 and 2 diabetes, is subcutaneously
Di Palma. For example, patients with diabetes or chronic opioid use are at increased risk for developing SIBO because of dysmotility, and older patients and those on proton-pump inhibitors (PPIs) ... Rochester, Minn., gastroenterologist Stephanie Hansel,